Metabolic checkpoints in immune cell reprogramming: rewiring immunometabolism for cancer therapy

Abstract Immune cell metabolism plays a pivotal role in regulating cellular proliferation, differentiation, and functional responses, collectively shaping immune responses within the tumor microenvironment (TME). Recent advancements increasingly highlight diverse metabolic phenotypes of immune cells...

Full description

Bibliographic Details
Published in:	Molecular Cancer
Main Authors:	Yingying Lv, Zongshang Li, Shutong Liu, Zhaokai Zhou, Jinling Song, Yuhao Ba, Siyuan Weng, Anning Zuo, Hui Xu, Peng Luo, Quan Cheng, Chuhan Zhang, Jingyuan Ning, Yukang Chen, Yuyuan Zhang, Zaoqu Liu, Xinwei Han
Format:	Article
Language:	English
Published:	BMC 2025-08-01
Subjects:	Immune cells Metabolic checkpoints Cancer immunotherapy Tumor microenvironment Metabolic reprogramming T cell
Online Access:	https://doi.org/10.1186/s12943-025-02407-6

Similar Items

Nanoparticle-Mediated Lipid Metabolic Reprogramming of T Cells in Tumor Microenvironments for Immunometabolic Therapy
by: Dongyoon Kim, et al.
Published: (2021-01-01)

Infiltrating treg reprogramming in the tumor immune microenvironment and its optimization for immunotherapy
by: Zhaokai Zhou, et al.
Published: (2024-09-01)

Histone lactylation bridges metabolic reprogramming and epigenetic rewiring in driving carcinogenesis: Oncometabolite fuels oncogenic transcription
by: Yu Zhang, et al.
Published: (2024-03-01)

T-Cell Metabolic Reprogramming in Atherosclerosis
by: Shuye Chang, et al.
Published: (2024-08-01)

Unlocking the potential of T‐cell metabolism reprogramming: Advancing single‐cell approaches for precision immunotherapy in tumour immunity
by: Lihaoyun Huang, et al.
Published: (2024-03-01)

Osteosarcoma immunometabolism: emerging mechanisms and clinical implications
by: Bowen Tan, et al.
Published: (2025-10-01)

Concise review: Cancer cell reprogramming and therapeutic implications
by: Xue Xiao, et al.
Published: (2022-10-01)

Reprogramming the immunosuppressive tumor microenvironment through nanomedicine: an immunometabolism perspective
by: Jieyu Liu, et al.
Published: (2024-09-01)

YAP and TAZ Mediators at the Crossroad between Metabolic and Cellular Reprogramming
by: Giorgia Di Benedetto, et al.
Published: (2021-03-01)

Immunometabolism Modulation in Therapy
by: Ezequiel Monferrer, et al.
Published: (2021-07-01)

Advances in reprogramming of energy metabolism in tumor T cells
by: Liu Xuekai, et al.
Published: (2024-02-01)

Ferroptosis in osteoarthritis: metabolic reprogramming, immunometabolic crosstalk, and targeted intervention strategies
by: Shenglin Xia, et al.
Published: (2025-06-01)

New Immunometabolic Strategy Based on Cell Type-Specific Metabolic Reprogramming in the Tumor Immune Microenvironment
by: Ji-Yong Sung, et al.
Published: (2022-02-01)

Nitric Oxide in Macrophage Immunometabolism: Hiding in Plain Sight
by: Erika M. Palmieri, et al.
Published: (2020-10-01)

Hypoxia Dictates Metabolic Rewiring of Tumors: Implications for Chemoresistance
by: Dimas Carolina Belisario, et al.
Published: (2020-12-01)

Delving Into the Dialogue between Epigenetic Modifications and Immunometabolism in Cancer
by: Xiaowen Xie, et al.
Published: (2025-09-01)

Metabolic reprogramming in cancer: Mechanisms and therapeutics
by: Shiqi Nong, et al.
Published: (2023-04-01)

Metabolic Sparks in the Liver: Metabolic and Epigenetic Reprogramming in Hepatic Stellate Cells Activation and Its Implications for Human Metabolic Diseases
by: Yeon Jin Roh, et al.
Published: (2025-05-01)

Immunosenescence and metabolic reprogramming in MASLD: an age-dependent immunometabolic vicious cycle and therapeutic opportunities
by: Yuxin Xu, et al.
Published: (2025-10-01)

Tumor glucose reprogramming suppresses cuproptosis: A review
by: Xiao-Hang Song, et al.
Published: (2025-08-01)

Single‐Cell Transcriptomic Analysis Identifies a Novel OLR1+ SLC7A7+ Liver‐Enriched Metastatic Subset With Immunometabolic Rewiring in Pancreatic Cancer
by: Xuan Yang, et al.
Published: (2025-11-01)

Editorial: Nanoparticle-Mediated Signaling Rewiring and Reprogramming of Immune Responses
by: Francisco J. Quintana, et al.
Published: (2022-05-01)

Advances in macrophage and T cell metabolic reprogramming and immunotherapy in the tumor microenvironment
by: Hua Cheng, et al.
Published: (2024-01-01)

The glucose metabolism reprogramming of yak Sertoli cells under hypoxia is regulated by autophagy
by: Rui MA, et al.
Published: (2025-04-01)

Research Hotspots and Trends in Global Cancer immunometabolism:A Bibliometric Analysis from 2000 to 2023
by: Chen S, et al.
Published: (2024-11-01)

Cancer immunometabolism: advent, challenges, and perspective
by: Qin Dang, et al.
Published: (2024-04-01)

Metabolic Reprogramming, Questioning, and Implications for Cancer
by: Pierre Jacquet, et al.
Published: (2021-02-01)

Metabolic reprogramming in efferocytosis
by: Qing Yan, et al.
Published: (2025-09-01)

Metabolic reprogramming by miRNAs in the tumor microenvironment: Focused on immunometabolism
by: Shadia Hamoud Alshahrani, et al.
Published: (2022-11-01)

Metabolic reprogramming via mitochondrial delivery for enhanced maturation of chemically induced cardiomyocyte‐like cells
by: Yena Nam, et al.
Published: (2024-12-01)

Polylactide Degradation Activates Immune Cells by Metabolic Reprogramming
by: Chima V. Maduka, et al.
Published: (2023-11-01)

Metabolic rewiring in keratinocytes by miR‐31‐5p identifies therapeutic intervention for psoriasis
by: Mao‐Jie Wang, et al.
Published: (2023-03-01)

Extracellular glucose triggers metabolic reprogramming of cultured human bronchial epithelial cells and indirect fibroblast activation
by: Sangmi S. Park, et al.
Published: (2024-09-01)

Host Circulating Immunometabolism-Associated Biomarkers for Early Diagnosis of Active Tuberculosis: Multi-Omics Screening with Experimental Validation
by: Yang Z, et al.
Published: (2025-08-01)

The metabolic reprogramming of γ-aminobutyrate in oral squamous cell carcinoma
by: Shi-Lian Wu, et al.
Published: (2024-04-01)

Metabolic Imbalance Effect on Retinal Müller Glial Cells Reprogramming Capacity: Involvement of Histone Deacetylase SIRT6
by: L Francisco Sanhueza Salas, et al.
Published: (2021-11-01)

A new era in melanoma immunotherapy: focus on DCs metabolic reprogramming
by: Mina Afrashteh Nour, et al.
Published: (2025-04-01)

Editorial: Cancer cell reprogramming: Impact on carcinogenesis and cancer progression
by: Yue Zhao, et al.
Published: (2023-02-01)

Single-Cell RNA Sequencing Analysis of the Immunometabolic Rewiring and Immunopathogenesis of Coronavirus Disease 2019
by: Furong Qi, et al.
Published: (2021-04-01)

Ignoring Gender-Based Immunometabolic Reprograming, a Risky Business in Immune-Based Precision Medicine
by: Vijay Kumar
Published: (2025-01-01)